ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study
Malaria Journal
◽
10.1186/s12936-016-1084-1
◽
2016
◽
Vol 15
(1)
◽
Cited By ~ 10
Author(s):
Neena Valecha
◽
Deepali Savargaonkar
◽
Bina Srivastava
◽
B. H. Krishnamoorthy Rao
◽
Santanu K. Tripathi
◽
...
Keyword(s):
Plasmodium Vivax
◽
Vivax Malaria
◽
Phase Iii
◽
Fixed Dose
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
◽
Plasmodium Vivax Malaria
◽
Dose Combination
Download Full-text
Related Documents
Cited By
References
Phase III, Multicenter Open-Label Study to Investigate the Efficacy of Elbasvir and Grazoprevir Fixed-Dose Combination for Eight Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, with Non-Severe Fibrosis
SSRN Electronic Journal
◽
10.2139/ssrn.3522580
◽
2020
◽
Author(s):
Armand Abergel
◽
Tarik Asselah
◽
Arianne Mallat
◽
Brigitte Chanteranne
◽
Frederic Faure
◽
...
Keyword(s):
Fixed Dose Combination
◽
Phase Iii
◽
Fixed Dose
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Treatment Naïve
◽
Dose Combination
◽
Severe Fibrosis
Download Full-text
Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate in comparison with chloroquine phosphate in children with acute uncomplicated Plasmodium vivax malaria: a phase III, randomised, multicentric study
Journal of Vector Borne Diseases
◽
10.4103/0972-9062.311781
◽
2021
◽
Vol 0
(0)
◽
pp. 0
Author(s):
AnupkumarR Anvikar
◽
Neena Valecha
◽
VimalKant Goyal
◽
DeoNidhi Mishra
◽
RashmiRanjan Das
◽
...
Keyword(s):
Plasmodium Vivax
◽
Vivax Malaria
◽
Fixed Dose Combination
◽
Phase Iii
◽
Fixed Dose
◽
Efficacy And Safety
◽
Multicentric Study
◽
Plasmodium Vivax Malaria
◽
Dose Combination
Download Full-text
Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study
Arthritis Care & Research
◽
10.1002/acr.21876
◽
2013
◽
Vol 65
(5)
◽
pp. 718-728
◽
Cited By ~ 48
Author(s):
Peter Nash
◽
Sauithree Nayiager
◽
Mark C. Genovese
◽
Alan J. Kivitz
◽
Kurt Oelke
◽
...
Keyword(s):
Rheumatoid Arthritis
◽
Phase Iii
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
◽
International Multicenter
Download Full-text
A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)
British Journal of Haematology
◽
10.1111/bjh.13029
◽
2014
◽
Vol 167
(2)
◽
pp. 243-251
◽
Cited By ~ 13
Author(s):
Huyen Tran
◽
Tim Brighton
◽
Andrew Grigg
◽
Simon McRae
◽
Joanna Dixon
◽
...
Keyword(s):
Idiopathic Thrombocytopenic Purpura
◽
Fixed Dose
◽
Chronic Idiopathic Thrombocytopenic Purpura
◽
Open Label
◽
Thrombocytopenic Purpura
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
Download Full-text
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2007.05.022
◽
2007
◽
Vol 57
(4)
◽
pp. 616-621
◽
Cited By ~ 58
Author(s):
Thomas K. Eigentler
◽
Anne Kamin
◽
Benjamin M. Weide
◽
Helmut Breuninger
◽
Ulrich M. Caroli
◽
...
Keyword(s):
Basal Cell Carcinoma
◽
Cell Carcinoma
◽
Basal Cell
◽
Low Risk
◽
Phase Iii
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
Download Full-text
Efficacy and tolerability of a switch to fixed-dose combination therapy with amlodipine besylate/benazepril hydrochloride after monotherapy with amlodipine besylate: Data from the African-American subpopulation of a practice-based, open-label study (the LOGIC study)*1
Current Therapeutic Research
◽
10.1016/s0011-393x(04)90028-8
◽
2004
◽
Vol 65
(2)
◽
pp. 138-148
Author(s):
M GATLIN
Keyword(s):
African American
◽
Combination Therapy
◽
Fixed Dose Combination
◽
Fixed Dose
◽
Amlodipine Besylate
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Dose Combination
Download Full-text
Phase 3, Multicenter Open‐Label study to investigate the efficacy of elbasvir and grazoprevir fixed‐dose combination for 8 weeks in treatment‐naïve, HCV GT1b‐infected patients, with non‐severe fibrosis
Liver International
◽
10.1111/liv.14502
◽
2020
◽
Vol 40
(8)
◽
pp. 1853-1859
◽
Cited By ~ 4
Author(s):
Armand Abergel
◽
Tarik Asselah
◽
Arianne Mallat
◽
Brigitte Chanteranne
◽
Frederic Faure
◽
...
Keyword(s):
Fixed Dose Combination
◽
Fixed Dose
◽
Open Label
◽
Phase 3
◽
Open Label Study
◽
Label Study
◽
Treatment Naïve
◽
Dose Combination
◽
Severe Fibrosis
Download Full-text
Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study
Malaria Journal
◽
10.1186/s12936-015-0982-y
◽
2015
◽
Vol 14
(1)
◽
Cited By ~ 5
Author(s):
Offianan Andre Toure
◽
Stephen Rulisa
◽
Anupkumar R. Anvikar
◽
Ballamudi S. Rao
◽
Pitabas Mishra
◽
...
Keyword(s):
Plasmodium Falciparum
◽
Plasmodium Falciparum Malaria
◽
Fixed Dose
◽
Efficacy And Safety
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Dose Combination
◽
Dispersible Tablets
◽
Uncomplicated Plasmodium Falciparum Malaria
Download Full-text
Assessment of the safety of non-fixed-dose combination of artesunate and amodiaquine for uncomplicated falciparum malaria in pregnancy: a nonrandomized open-label study
Journal of Pharmaceutical Health Services Research
◽
10.1111/jphs.12166
◽
2017
◽
Vol 8
(1)
◽
pp. 31-38
◽
Cited By ~ 4
Author(s):
Osede Ignis Iribhogbe
◽
Emmanuel Odion Igue
◽
Marylove Odianosen
Keyword(s):
Falciparum Malaria
◽
Malaria In Pregnancy
◽
Fixed Dose Combination
◽
Uncomplicated Falciparum Malaria
◽
Fixed Dose
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Dose Combination
◽
In Pregnancy
Download Full-text
A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy
Supportive Care in Cancer
◽
10.1007/s00520-011-1239-0
◽
2011
◽
Vol 20
(7)
◽
pp. 1507-1514
◽
Cited By ~ 22
Author(s):
Kenjiro Aogi
◽
Hiroshi Sakai
◽
Hirohisa Yoshizawa
◽
Norikazu Masuda
◽
Nobuyuki Katakami
◽
...
Keyword(s):
Emetogenic Chemotherapy
◽
Nausea And Vomiting
◽
Phase Iii
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close